Genedrive (GDR) RNS Announcements

Add to Alert list
Date Time Source Announcement
04 Nov 2025 07:00 AM
RNS
MT-RNR1 ID Kit in Dublin’s Rotunda Hospital
31 Oct 2025 07:00 AM
RNS
Potential Shareholder Loan
29 Oct 2025 04:35 PM
RNS
Holding(s) in Company
28 Oct 2025 07:00 AM
RNS
MOU with Kingdom of Saudi Arabia for MT-RNR1 ID
24 Oct 2025 04:30 PM
RNS
Application for Listing & Total Voting Rights
15 Oct 2025 10:49 AM
RNS
Result of General Meeting
10 Oct 2025 01:32 PM
RNS
Holding(s) in Company
10 Oct 2025 01:31 PM
RNS
Holding(s) in Company
10 Oct 2025 09:00 AM
RNS
Holding(s) in Company
09 Oct 2025 10:23 AM
RNS
Further re Equity Financing
06 Oct 2025 07:00 AM
RNS
Further re Equity Financing
02 Oct 2025 06:18 PM
RNS
Holding(s) in Company
01 Oct 2025 12:31 PM
RNS
Holding(s) in Company
01 Oct 2025 12:30 PM
RNS
Holding(s) in Company
30 Sep 2025 09:52 AM
RNS
Holding(s) in Company
29 Sep 2025 05:03 PM
RNS
Holding(s) in Company
29 Sep 2025 03:00 PM
RNS
Publication of Circular and Notice of GM
29 Sep 2025 07:00 AM
RNS
Result of Retail Offer
24 Sep 2025 07:00 AM
RNS
Completion of Placing
23 Sep 2025 05:03 PM
RNS
Proposed Retail Offer
23 Sep 2025 04:59 PM
RNS
Proposed Placing to raise a minimum of £3 million
23 Sep 2025 09:00 AM
RNS
Holding(s) in Company
23 Sep 2025 09:00 AM
RNS
Holding(s) in Company
15 Sep 2025 04:24 PM
RNS
Result of General Meeting
10 Sep 2025 04:15 PM
RNS
Holding(s) in Company
10 Sep 2025 04:15 PM
RNS
Holding(s) in Company
29 Aug 2025 12:00 PM
RNS
Proposed Share Capital Reorganisation & GM
21 Aug 2025 07:00 AM
RNS
Scotland’s Public Health Minister visit
14 Aug 2025 10:35 AM
RNS
Comment re: Share Price Movement
11 Aug 2025 07:00 AM
RNS
Trading update
30 May 2025 07:00 AM
RNS
Block Listing Returns
30 May 2025 07:00 AM
RNS
CE-certification
13 May 2025 07:00 AM
RNS
CYP2C19-ID Kit used to support expansion
02 May 2025 01:30 PM
RNS
CYP2C19 ID Kit CE-IVD certification update
02 Apr 2025 07:01 AM
RNS
Additional grant funding under DEVOTE programme
02 Apr 2025 07:00 AM
RNS
Receipt of R&D tax credit
01 Apr 2025 07:00 AM
RNS
Result of RetailBook Offer
27 Mar 2025 03:30 PM
RNS
RetailBook Offer
27 Mar 2025 03:29 PM
RNS
Half-year Report
27 Mar 2025 03:28 PM
RNS
Equity Fundraise
17 Mar 2025 11:04 AM
RNS
Scottish Government testing programme investment
14 Mar 2025 07:00 AM
RNS
CYP2C19-ID Kit adopted for routine clinical use
30 Dec 2024 11:54 AM
RNS
Result of AGM
27 Dec 2024 07:00 AM
RNS
Genedrive® CYP2C19-ID Kit performance published
20 Dec 2024 12:16 PM
RNS
Grant of Options
20 Dec 2024 12:12 PM
RNS
Director/PDMR Shareholding
05 Dec 2024 03:00 PM
RNS
Posting of annual report and notice of AGM
29 Nov 2024 01:00 PM
RNS
Block listing returns
29 Nov 2024 07:00 AM
RNS
Final Results
22 Nov 2024 07:00 AM
RNS
Notice of Results

Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests. 

 Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss

Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.

GDR share price launched at 129p in 2007. 

UK 100